ArticleFrontiers in cellular and infection microbiology2023

Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR)

Yixin Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.